26th Congress of the European
Association for Cancer Research
EACR 2021 Congress: Innovative Cancer Science
EACR 2021 - Innovative Cancer Science: Better Outcomes Through Research
09-12 June 2021 | Torino, Italy
Update 02 September 2020: Given the COVID-19 pandemic and global restrictions, many of us are wondering when we will be able to come together again as a scientific community. We currently plan to go ahead with the EACR Congress in Torino, 9-12 June 2021. But we recognise that there is still some uncertainty around large events and international travel.
That’s why as well as planning for the in-person congress we’ve decided to plan for the possibility of a virtual congress with a virtual poster exhibition, in case the in-person event can’t happen. This means that anyone who submits an abstract for EACR 2021 will be able to present it as long as it is accepted – either in Torino, or if this can’t go ahead then at the virtual event.
We hope that this will provide reassurance to anyone who is thinking about submitting their abstract for the congress. Abstract submission is open now – you can submit here.
About the Congress
EACR 2021 is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.
The European Association for Cancer Research (EACR) is a non-profit membership association dedicated to the advancement of cancer research. We have been bringing cancer researchers together at our congress and conferences since 1968, and EACR 2021 is our 26th congress. Click here to find out more about us and join as a member.
EACR 2021 session topics include
- Artificial Intelligence
- Biology of Paediatric and Young Adult Cancer
- Brain Cancer Metastasis
- Breast Cancer Lineages
- Cancer Cells and their Neighbours
- Cancer Genomics
- Cell Cycle and Senescence
- DNA Damage
- DNA Repair
- Early Detection of Cancer and Early Disease
- Evolutionary Dynamics and Therapy Resistance
- Fate and Cell Communication
- From Genes to Cures
- From Tissue to Single Cells
- Immuno Genomics
- Innovation and Clinical Trials
- Innovative Cancer Models (Avatars)
- Intra Vital Imaging and Metastasis
- Metabolism Meets the Epigenome
- Microbes, Viruses and Cancer
- Rational Treatment Combinations
- Targeting MYC and RAS Driven Cancer
Key dates
Bursary application deadline
24 February 2021
Abstract submission deadline
08 March 2021
Early registration rate
12 April 2021
Regular registration rate
03 May 2021
Late registration rate
24 May 2021
Organising and Scientific Programme Committee
- Alberto Bardelli (Italy) (Chair)
- Anton Berns (Netherlands)
- Carlos Caldas (UK)
- Arkaitz Carracedo (Spain)
- Vincenzo Costanzo (Italy)
- Leonor David (Portugal)
- Caroline Dive (UK)
- Richard Marais (UK)
- Ruth Palmer (Sweden)
- Daniel Peeper (Netherlands)
- Joan Seoane (Spain)
- Yardena Samuels (Israel)
- Therese Sørlie (Norway)
- Hugues de Thé (France)
- Andreas Trumpp (Germany)
- Emmy Verschuren (Finland)
Sorry. You need to upgrade your browser
You are using Internet Explorer 8
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.
Thank you.